Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
Clinical trial NCT03691012 · UNKNOWN
Trial details
- NCT number
- NCT03691012
- Sponsor
- Walter and Eliza Hall Institute of Medical Research
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-05-09
- Primary completion
- 2020-12-31
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.